首页> 外国专利> 4-OXO-1-(3-SUBSTITUTED PHENYL)-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, METHOD FOR TREATMENT AND PROPHYLAXIS AND METHOD FOR IMPROVING COGNITIVE ABILITY IN HEALTH SUBJECT

4-OXO-1-(3-SUBSTITUTED PHENYL)-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, METHOD FOR TREATMENT AND PROPHYLAXIS AND METHOD FOR IMPROVING COGNITIVE ABILITY IN HEALTH SUBJECT

机译:4-OXO-1-(3-取代的苯基)-1,4-二氢-1,8-萘啶-3-羧酰胺,基于其的药物组合物,治疗和预防方法以及改善健康受试者认知能力的方法

摘要

FIELD: organic chemistry, medicine, pharmacy.;SUBSTANCE: invention describes novel 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamides of the general formula (I): or their pharmaceutically acceptable salts wherein Ar means phenyl or thienyl; Y means -COOH, (C1-C6)-alkyl, (C1-C4-alkyl)n-COOH, (C3-C4)-cycloalkyl-COOH wherein (C1-C6)-alkyl and (C3-C4)-cycloalkyl are optionally substituted with halogen atom, hydroxy-group, -CN, and (C1-C4)-alkyl-substitutes are bound optionally to form (C3-C4)-cycloalkyl and wherein n = 0, 1, 2, 3 or 4; R means hydrogen atom (H) or (C1-C6)-alkyl; R1 means H, (C1-C6)-alkyl optionally substituted with halogen atom; (C3-C6)-cycloalkyl optionally substituted with halogen atom, (C1-C6)-alkyl, -OH, -CN or phenyl; (C1-C6-alkyl)-SOp-(C1-C6)-alkyl wherein p = 0, 1 or 2; or 1,3,4-thiadiazolyl substituted with halogen-(C1-C6)-alkyl; or R1 means methyl substituted with cyclopropyl; R2 means H, halogen atom or (C1-C6)-alkyl; R3 means H or halogen atom, and pharmaceutical compositions based on thereof. Compounds possess inhibitory activity and can be used in treatment of asthma and inflammatory diseases.;EFFECT: valuable medicinal properties of compounds and pharmaceutical compositions, improved method of treatment.;22 cl, 4 tbl, 30 ex
机译:领域:本发明描述了通式(I)的新颖的4-氧代-1-(3-取代的苯基)-1,4-二氢-1,8-萘啶-3-羧酰胺:<图像文件=“ 00000002.GIF” he =“ 65” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 50” />或其药学上可接受的盐,其中Ar表示苯基或噻吩基; Y表示-COOH,(C 1 -C 6 )-烷基,(C 1 -C 4 -烷基) n -COOH,(C 3 -C 4 )-环烷基-COOH,其中(C 1 - C 6 )-烷基和(C 3 -C 4 )-环烷基任选地被卤素原子,羟基,-CN,和(C 1 -C 4 )-烷基取代基可选地结合形成(C 3 -C 4 1 -C 6 )-烷基; R 1 是指H,(C 1 -C 6 )-烷基,其任选地被卤素原子取代; (C 3 -C 6 )-环烷基,可选地被卤素原子取代,(C 1 -C 6 ) -烷基,-OH,-CN或苯基; (C 1 -C 6 -烷基)-SO p -(C 1 -C 6 )-烷基,其中p = 0、1或2;或被卤素-(C 1 -C 6 )-烷基取代的1,3,4-噻二唑基; R 1 是指被环丙基取代的甲基; R 2 是指H,卤原子或(C 1 -C 6 )-烷基; R 3 是指H或卤素原子,以及基于其的药物组合物。化合物具有抑制活性,可用于治疗哮喘和炎症性疾病。效果:化合物和药物组合物的宝贵药用特性,改进的治疗方法; 22 cl,4 tbl,30 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号